Type III Hereditary Angioedema
Links shared publicly online about this topic
Angioedema, Hereditary: eMedicine Dermatology
emedicine.medscape.com — “Overview: Hereditary angioedema (HAE) is an autosomal dominant disorder of C1 inhibitor (C1-INH) deficiency manifested by painless, nonpruritic, nonpitting swelling of the skin. Type I HAE is defined by low plasma levels of a normal C1-INH protein. ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 17, 2010 at 8:29 pm By:
Susan Scroggins Active Health Library and Health Advocate
Hereditary angioedema occurs in 1 in 10-50,000 people in the U.S. Learn more about this condition and its severity. http://bit.ly/bq2eNv
Angioedema: eMedicine Emergency Medicine
emedicine.medscape.com — “Overview: Many types of angioedema are described in the literature: hereditary angioedema (HAE) types I, II, and III; acquired angioedema; drug-induced angioedema (associated with angiotensin-converting enzyme [ACE] inhibitors and angiotensin II receptor blockers [ARBs]); urticaria-associated angioedema; and ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 15, 2010 at 2:34 pm By:
Medscape Emergency Health Site
New drug ecallantide is indicated for acute attacks of hereditary angioedema. See eMedicine's Angioedema article. http://bit.ly/bm88Kk
CSL Behring Announces FDA Approval of Berinert, First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema in U.S.
drugs.com — “Berinert (C1 esterase inhibitor (human)) is used to treat hereditary angioedema. Includes Berinert side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 12, 2009 at 11:38 pm By:
FDA Approves Berinert for Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema - http://bit.ly/lz9bc
Shire Reports Positive Efficacy And Safety Results From FAST-3 Study Of Firazyr® (icatibant) For Acute Attacks Of Hereditary Angioedema
medicalnewstoday.com — “Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced topline results from FAST-3 (For Angioedema Subcutaneous Treatment), the largest of the Phase I” View full resource at medicalnewstoday.com
Most Recently Shared on December 2, 2010 at 4:37 pm By:
Shire Reports Positive Efficacy And Safety Results From FAST-3 Study Of Firazyr® (icatibant) For Acute Attacks Of Hered.. http://dld.bz/8WHy
Shire announces FDA PDUFA date for FIRAZYR NDA in treatment of acute attacks of hereditary angioedema
news-medical.net — “Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of August 25, 2011 for the review of the New Drug Application (NDA) for FIRAZYR(R) (icatibant) for the treatment of acute attacks (Types I and II) of hereditary angioedema (HAE). This 6 month review timeline is consistent with review as a Class II resubmission.” View full resource at news-medical.net
Most Recently Shared on March 21, 2011 at 12:41 pm By:
Shire announces FDA PDUFA date for FIRAZYR NDA in treatment of acute attacks of hereditary angioedema: Shire plc... http://bit.ly/eNRrXw
Shire Reports Positive Efficacy and Safety Results From FAST-3 Study of FIRAZYR (icatibant) for Acute Attacks of Hereditary Angioedema - Drugs.com MedNews
drugs.com — “DUBLIN, December 1, Shire plc (LSE SHP, NASDAQ SHPGY), the global specialty biopharmaceutical company, today announced topline results from FAST-3 (For Angioede” View full resource at drugs.com
Most Recently Shared on December 1, 2010 at 2:06 pm By:
Drugs and Devices OW OW Health
Shire Reports Positive Efficacy and Safety Results From FAST-3 Study of FIRAZYR (icatibant) for Acute Atta... http://bit.ly/eA6Fyc #drug
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Susan Scroggins
Passionate about sharing quality health resources for good health. Content curator and organizer at organizedwisdom.com.
-
Medscape Emergency
Latest medical news, articles, and features from Medscape Emergency Medicine.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement
